X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare GSK Pharma with Torrent Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GSK PHARMA vs TORRENT PHARMA - Comparison Results

GSK PHARMA    Change

GSK Pharma is one of the leading MNC pharma companies in the Indian market. It is a 50.7% subsidiary of GlaxoSmithKline Plc, one of the world's largest pharma companies. GSK Pharma's product portfolio boasts of some of the leading brands like Augment... More

TORRENT PHARMA 
   Change

Torrent Pharmaceuticals Ltd. is the flagship company of the Torrent Group set up in 1959. Based in Ahmedabad, it was promoted by Mr U.N. Mehta initially as Trinity Laboratories Ltd. and was later renamed to its current name. The company derives its r... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GSK PHARMA TORRENT PHARMA GSK PHARMA/
TORRENT PHARMA
 
P/E (TTM) x 59.9 25.7 233.2% View Chart
P/BV x 11.7 6.3 186.8% View Chart
Dividend Yield % 2.1 3.2 66.1%  

Financials

 GSK PHARMA   TORRENT PHARMA
EQUITY SHARE DATA
    GSK PHARMA
Mar-16
TORRENT PHARMA
Mar-16
GSK PHARMA/
TORRENT PHARMA
5-Yr Chart
Click to enlarge
High Rs3,8501,720 223.8%   
Low Rs2,9661,134 261.6%   
Sales per share (Unadj.) Rs332.3394.5 84.2%  
Earnings per share (Unadj.) Rs44.3101.8 43.5%  
Cash flow per share (Unadj.) Rs47.2116.3 40.6%  
Dividends per share (Unadj.) Rs50.0040.00 125.0%  
Dividend yield (eoy) %1.52.8 52.3%  
Book value per share (Unadj.) Rs202.7200.3 101.2%  
Shares outstanding (eoy) m84.70169.22 50.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x10.33.6 283.6%   
Avg P/E ratio x76.914.0 548.8%  
P/CF ratio (eoy) x72.212.3 588.3%  
Price / Book Value ratio x16.87.1 236.0%  
Dividend payout %112.939.3 287.2%   
Avg Mkt Cap Rs m288,643241,435 119.6%   
No. of employees `0004.610.9 42.3%   
Total wages/salary Rs m4,4348,559 51.8%   
Avg. sales/employee Rs Th6,104.56,129.6 99.6%   
Avg. wages/employee Rs Th961.6785.8 122.4%   
Avg. net profit/employee Rs Th813.71,581.3 51.5%   
INCOME DATA
Net Sales Rs m28,14866,764 42.2%  
Other income Rs m1,2182,156 56.5%   
Total revenues Rs m29,36668,920 42.6%   
Gross profit Rs m4,77427,204 17.5%  
Depreciation Rs m2482,461 10.1%   
Interest Rs m01,859 0.0%   
Profit before tax Rs m5,74425,041 22.9%   
Minority Interest Rs m00 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m26-1,403 -1.9%   
Tax Rs m2,0186,414 31.5%   
Profit after tax Rs m3,75217,224 21.8%  
Gross profit margin %17.040.7 41.6%  
Effective tax rate %35.125.6 137.2%   
Net profit margin %13.325.8 51.7%  
BALANCE SHEET DATA
Current assets Rs m21,46246,622 46.0%   
Current liabilities Rs m10,53632,843 32.1%   
Net working cap to sales %38.820.6 188.1%  
Current ratio x2.01.4 143.5%  
Inventory Days Days6874 91.1%  
Debtors Days Days1679 20.8%  
Net fixed assets Rs m4,71739,029 12.1%   
Share capital Rs m847846 100.1%   
"Free" reserves Rs m16,30831,400 51.9%   
Net worth Rs m17,17133,890 50.7%   
Long term debt Rs m1618,637 0.1%   
Total assets Rs m30,62090,136 34.0%  
Interest coverage xNM14.5-  
Debt to equity ratio x00.5 0.2%  
Sales to assets ratio x0.90.7 124.1%   
Return on assets %12.321.2 57.9%  
Return on equity %21.950.8 43.0%  
Return on capital %33.648.5 69.2%  
Exports to sales %043.3 0.0%   
Imports to sales %15.16.9 219.2%   
Exports (fob) Rs m428,934 0.0%   
Imports (cif) Rs m4,2374,584 92.4%   
Fx inflow Rs m51929,185 1.8%   
Fx outflow Rs m8,3206,021 138.2%   
Net fx Rs m-7,80123,165 -33.7%   
CASH FLOW
From Operations Rs m1,38627,132 5.1%  
From Investments Rs m5,010-7,014 -71.4%  
From Financial Activity Rs m-6,383-14,352 44.5%  
Net Cashflow Rs m125,767 0.2%  

Share Holding

Indian Promoters % 0.0 71.5 -  
Foreign collaborators % 50.7 0.0 -  
Indian inst/Mut Fund % 10.2 7.0 145.3%  
FIIs % 23.8 12.6 188.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 15.4 8.8 175.0%  
Shareholders   102,036 26,511 384.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GSK PHARMA With:   PIRAMAL ENTERPRISES  ABBOTT INDIA  PLETHICO PHARMA  DR. REDDYS LAB  NOVARTIS  

Compare GSK PHARMA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades in Red; Auto Stocks Witness Selling(01:30 pm)

After opening the day flat, share markets in India continued to witness selling pressure and are currently trading in red. Sectoral indices are trading on a mixed note with stocks in the metals sector.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Profitable Investment in the History of the World(Vivek Kaul's Diary)

Aug 8, 2017

'Yes, it looks like a bubble. And, yes, it's like buying a lottery ticket. But there's something happening that has never happened before. It's an evolutionary leap in money itself.'

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

GSK PHARMA SHARE PRICE


Aug 21, 2017 02:45 PM

TRACK GSK PHARMA

  • Track your investment in GSK PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE GSK PHARMA WITH

MARKET STATS